LC

LSV Capital

Europe, England, United Kingdom, London

Description

LSV Capital is a investment firm.

Investor Profile

LSV Capital has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B rounds (top funding stages).
  • Majority of deals are located in China.
  • Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.

Stage Focus

  • Series B (100%)

Country Focus

  • China (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does LSV Capital frequently co-invest with?

CBC Group
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
LongRiver Investments
Asia, Shanghai, China, Xuhui
Co-Investments: 1
MSA Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
F-Prime Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Gaorong Capital
Asia, Beijing, China, Wangjing
Co-Investments: 1
K2 Venture Capital
Asia, Krung Thep, Thailand, Bangkok
Co-Investments: 1
Co-Investments: 1
Eight Roads Ventures
Europe, England, United Kingdom, London
Co-Investments: 1
Invus
North America, New York, United States, New York
Co-Investments: 1
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 1

What are some of recent deals done by LSV Capital?

Sironax

Beijing, Beijing, China

Sironax is a clinical-stage biotechnology company that develops novel products and treatments for age-related degenerative diseases.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series BAug 2, 2022
Amount Raised: $200,000,000